Dsm-firmenich slips as slight Q3 beat, guidance hike 'not enough'
** Shares in dsm-firmenich DSFIR.AS fall about 4%, analysts point out the Dutch ingredients maker's slight Q3 beat and FY growth outlook hike are "not enough"
** Dsm-firmenich reports Q3 adjusted EBITDA of €482 million ($541.29 million), slightly above a company-provided consensus of €478 million; it forecasts FY growth of around 5%, up from previous 2-4%
** "Is 5% enough?" Jefferies asks, expecting post-results share price pressure
** "The stock is up ~10% over the past month, suggesting expectations have moved higher; as such, an in-line print may not be enough today," J.P. Morgan says
** JPM sees implied Q4 organic sales growth of about 5% as "reassuring", but Q3-Q4 seasonality points to Q4 adjusted EBITDA in line with or slightly below consensus
($1 = 0.8905 euros)